These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 752868)

  • 1. First results of a randomized trial on immunotherapy of head and neck tumors.
    Amiel JL; Sancho-Garnier H; Vandenbrouck C; Eschwege F; Droz JP; Schwaab G; Wibault P; Stromboni M; Rey A
    Recent Results Cancer Res; 1978; 68():318-23. PubMed ID: 752868
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of adjuvant BCG immunotherapy in head and neck cancer.
    Taylor SG; Sisson GA; Bytell DE; Raynor WJ
    Arch Otolaryngol; 1983 Aug; 109(8):544-9. PubMed ID: 6347154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The controversial role of BCG in the treatment of squamous cell carcinoma of the head and neck.
    Medina JE
    Arch Otolaryngol; 1983 Aug; 109(8):543. PubMed ID: 6870648
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of BCG adjuvant immunotherapy for melanoma of the head and neck.
    Eilber FR; Townsend CM; Morton DL
    Am J Surg; 1976 Oct; 132(4):476-9. PubMed ID: 1015538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.
    Suen JY; Richman SP; Livingston RB; Hersh EM; Craig R; Tonymon K
    Am J Surg; 1977 Oct; 134(4):474-8. PubMed ID: 911030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers.
    Cunningham TJ; Antemann R; Paonessa D; Sponzo RW; Steiner D
    Ann N Y Acad Sci; 1976; 277(00):339-44. PubMed ID: 1069553
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant chemoimmunotherapy in advanced lesions of the head and neck.
    Eilber FR; Morton DL
    AJR Am J Roentgenol; 1976 May; 126(5):1082-7. PubMed ID: 178233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoimmunotherapy for cancer of the head and neck.
    Donaldson RC
    Am J Surg; 1973 Oct; 126(4):507-12. PubMed ID: 4743834
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.
    Eilber FR; Morton DL; Holmes EC; Sparks FC; Ramming KP
    N Engl J Med; 1976 Jan; 294(5):237-40. PubMed ID: 1244548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience in using the extract (SSM) from tubercle bacilli for patients with head and neck tumors (author's transl)].
    Sakai S; Yamamoto K; Suzuki S; Murata M
    Nihon Gan Chiryo Gakkai Shi; 1977 Sep; 12(3):321-7. PubMed ID: 915354
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Melanoma treatment--BCG as adjuvant.
    Stein RS
    N Engl J Med; 1976 Apr; 294(18):1011. PubMed ID: 1256503
    [No Abstract]   [Full Text] [Related]  

  • 13. BCG as adjuvant immunotherapy for neoplasia.
    Hersh EM; Gutterman JU; Mavligit GM
    Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled study of combined methotrexate, BCG, and INH therapy for squamous cell carcinoma of the head and neck.
    Woods JE; DeSanto LW; Ritts RE
    Surg Clin North Am; 1977 Aug; 57(4):769-78. PubMed ID: 897965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
    Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
    Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant intralesional and systemic Corynebacterium parvum immunotherapy for surgically treated head and neck cancer.
    Beatty JD; Terz JJ; Brown PW; Lawrence W; Schuller GB; Kaplan AM
    Surg Forum; 1978; 29():155-7. PubMed ID: 401122
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial.
    Fisher RI; Terry WD; Hodes RJ; Rosenberg SA; Makuch R; Gordon HG; Fisher SG
    Surg Clin North Am; 1981 Dec; 61(6):1267-77. PubMed ID: 7031934
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E; Jauhiainen K; Alfthan O
    Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.
    Hoover HC; Surdyke MG; Dangel RB; Peters LC; Hanna MG
    Cancer; 1985 Mar; 55(6):1236-43. PubMed ID: 3882219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.